Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model

Apr 5

Written By Yiran Gan

2020.09.30

CH Lin, SI Chiu, TF Chen, JS Roger Jang and MJ Chiu

Int. J. Mol. Sci. 2020, 21(18), 6914

https://www.mdpi.com/1422-0067/21/18/6914

Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline

Plasma Biomarkers Ascertained with Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review